ClinicalTrials.gg

Program

Curcumin/Polyphenols-containing Botanical Agent APG-157

Its studies are mostly in Squamous Cell Carcinoma of Head and Neck · Glioblastoma, led by Aveta Biomics.

Furthest: phase 3, since Jun 8, 20263 company-led studies, 3 open or runningNext primary completion: Dec 2026 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Aveta Biomics33 open or runningphase 3since Jun 8, 2026Mar 16, 2022Dec 2026phase 2 · NCT05312710

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 16, 2022First study: phase 2 study in Head and Neck NeoplasmsFirst studyNCT05312710 · 24 enrolled · United States
  2. Aug 9, 2023Phase 2 study in GliomaNCT06011109 · 30 enrolled · United States
  3. Jun 8, 2026Phase 3 study in Head and Neck NeoplasmsPhase 3 reachedNCT07667296 · 826 planned

Ahead

  1. Dec 2026Primary completion: phase 2 study in Head and Neck NeoplasmsNCT05312710
  2. Dec 31, 2026Primary completion: phase 2 study in GliomaNCT06011109
  3. Dec 2031Primary completion: phase 3 study in Head and Neck NeoplasmsNCT07667296

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07667296Head and Neck Neoplasms3Not yet recruitingDec 2031826
NCT06011109Glioma · United States2Active, not recruitingDec 31, 202630
NCT05312710Head and Neck Neoplasms · United States2Active, not recruitingDec 202624

How it is read

Names in the registry

  • “APG-157”, 3 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.